# Patient Education and Duloxetine, Alone and in Combination, for Patients With Multisystem Functional Somatic Disorder

> **NCT06232473** · PHASE4 · RECRUITING · sponsor: **Aarhus University Hospital** · enrollment: 424 (estimated)

## Conditions studied

- Functional Disorder

## Interventions

- **BEHAVIORAL:** Patient Education
- **DRUG:** Duloxetine
- **DRUG:** Benztropine Mesylate 0.5 MG and passive placebo RAP
- **BEHAVIORAL:** Enhanced usual care

## Key facts

- **NCT ID:** NCT06232473
- **Lead sponsor:** Aarhus University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-01
- **Primary completion:** 2027-11-01
- **Final completion:** 2029-11-01
- **Target enrollment:** 424 (ESTIMATED)
- **Last updated:** 2024-01-30

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06232473

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06232473, "Patient Education and Duloxetine, Alone and in Combination, for Patients With Multisystem Functional Somatic Disorder". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06232473. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*